A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1

Background: Clear cell renal cell carcinoma (ccRCC) is the most prevalent histologic subtype of kidney cancers in adults, which could be divided into two distinct subgroups according to the BRCA1 associated protein-1 (BAP1) mutation status. In the current study, we comprehensively analyzed the genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Yu-Zheng, Xu, Lu-Wei, Zhou, Chang-Cheng, Lu, Tian-Ze, Yao, Wen-Tao, Wu, Ran, Zhao, You-Cai, Xu, Xiao, Hu, Zhi-Kai, Wang, Min, Yang, Xiao-Bing, Zhou, Liu-Hua, Zhong, Bing, Xu, Zheng, Li, Wen-Cheng, Zhu, Jia-Geng, Jia, Rui-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595094/
https://www.ncbi.nlm.nih.gov/pubmed/28900502
http://dx.doi.org/10.7150/jca.20234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595094/
https://www.ncbi.nlm.nih.gov/pubmed/28900502
http://dx.doi.org/10.7150/jca.20234

Ejemplares similares